BioCentury
ARTICLE | Company News

Alexion management update

February 25, 2013 8:00 AM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology, Autoimmune, Cancer Departing: Tom Dubin as chief legal officer Hired: John Moriarty as SVP and general counsel; and Fr...